E-ISSN: 1305-3612
    Splenic artery embolization: a single center experience on the safety, efficacy, and clinical outcomes
    PDF
    Cite
    Share
    Request
    Interventional Radiology - Original Article
    VOLUME: 19 ISSUE: 1
    P: 49-55
    January 2013

    Splenic artery embolization: a single center experience on the safety, efficacy, and clinical outcomes

    Diagn Interv Radiol 2013;19(1):49-55
    DOI: 10.4261/1305-3825.DIR.5895-12.1
    Ron C. Gaba 1
    Jeremy R. Katz 1
    Ahmad Parvinian 2
    Steven Reich 1
    Benedictta O. Omene 3
    Felix Y. Yap 1
    Charles A. Owens 3
    M. Grace Knuttinen 3
    James T. Bui 3
    1. Department of Radiology, University of Illinois at Chicago, Chicago, Illinois, USA
    2. Department of Radiology, University of Illinois College of Medicine, Chicago, Illinois, USA
    3. Department of Radiology, University of Illinois at Chicago, Chicago, IL, USA
    No information available.
    No information available
    Received Date: 30.03.2012
    Accepted Date: 31.05.2012
    PDF
    Cite
    Share
    Request

    ABSTRACT

    PURPOSE

    We aimed to assess the safety, ef„cacy, and clinical outcomes of splenic artery embolization (SAE).

    MATERIALS AND METHODS

    A total of 50 patients (male:female, 33:17; mean age, 49 years) who underwent 50 SAEs between 1998 and 2011 were retrospectively studied. The procedure indications included aneurysm or pseudoaneurysm (n=15), gastric variceal hemorrhage (n=15), preoperative reduction of surgical blood loss (n=9), or other (n=11). In total, 22 procedures were elective, and 28 procedures were urgent or emergent. The embolic agents included coils (n=50), gelatin sponges (n=15), and particles (n=4). The measured outcomes were the technical success of the procedure, ef„cacy, side effe cts, and the 30-day morbidity and mortality rates.

    RESULTS

    All embolizations were technically successful. The procedure ef„cacy was 90%; „ve patients (10%) had a recurrent hemorrhage requiring a secondary intervention. Side effects included hydrothorax (n=26, 52%), thrombocytosis (n=16, 32%), thrombocytopenia (n=13, 26%), and postembolization syndrome (n=11, 22%). Splenic infarcts occurred in 13 patients (26%). The overall and procedure-speci„c 30-day morbidity rates were 38% (19/50) and 14% (splenoportal thrombosis, 3/50; encapsulated bacterial infection, 1/50; splenic abscess, 1/50; femoral hematoma requiring surgery, 1/50; hydrothorax requiring drainage, 1/50). The overall a nd procedurespeci„c 30-day mortality rates were 8% (4/50) and 0%. The multivariate analysis showed that advanced patient age (P = 0.037), postprocedure thrombocytopenia ( P = 0.008), postprocedure hydrothorax (P = 0.009), and the need for a secondary intervention (P = 0.004) predicted the 30-day morbidity, while renal insuf„ciency (P < 0.0001), preprocedure hemodynamic instability (P = 0.044), and preprocedure leu- kocytosis (P < 0.0001) were prognostic factors for the 30-day mortality.

    CONCLUSION

    SAE was performed with high technical success and ef„cacy, but the outcomes showed nontrivial morbidity rates. Elderly patients with thrombocytopenia and hydrothorax after SAE, and patients who require secondary interventions, should be monitored for complications.

    References

    2024 ©️ Galenos Publishing House